AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Become a member today!
Submit Abstracts for Biothreats 2017
Antibacterial Development Conference

David Serwadda, MBChB, MSc, MMed, MPH, is Professor of Professor of Disease control and Environmental Health , Makerere School of Public Health, and former Dean of the Makerere University School of Public Health (MUSPH) in Uganda. He is also a founding member of Accordia Global Health Foundation’s Academic Alliance. Dr. Serwadda is an infectious disease epidemiologist, who in the early 1980s was one of the first physicians in Uganda to recognize the new disease that became known as AIDS. He has worked continuously on HIV-related research and prevention ever since. He received his MBChB and MMed (Internal Medicine) from Makerere University and an MPH from Johns Hopkins Bloomberg School of Public Health. He has been a senior investigator on the Rakai Program since its inception in 1988, and is the Ugandan principal investigator on the ongoing NIH-funded “Trial of Male Circumcision for HIV Prevention.” He has been instrumental in the scientific design and management of the project and has provided critical liaison between the project, the local community, Ugandan political and policy decision makers, the Ugandan Ministry of Health, and international agencies including UNAIDS, WHO, and the World Bank.

As found on: